ConductScience.org, home

Trial · NCT05913674

Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)

NCT05913674, Phase 2, Recruiting, Ciusss de L'Est de l'Île de Montréal

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC). Trials, record NCT05913674. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05913674

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
NCT number
NCT05913674
Status
Recruiting
Phases
Phase 2
Enrollment
25 participants, estimated
Lead sponsor
Ciusss de L'Est de l'Île de Montréal
Conditions
Peritoneal Carcinomatosis, Appendiceal Neoplasms, Colorectal Cancer Metastatic
Interventions
Modified early post-operative intraperitoneal chemotherapy (mEPIC)
First posted
2023-06-22
Last updated
2026-05-14

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryFeasibility of mEPIC2 days (assessed at the end of mEPIC protocol).Evaluate mEPIC completion rate in patients with colorectal and appendicular cancer with peritoneal carcinomatosis treated with CRS and HIPEC and followed by mEPIC in a tertiary Canadian centre.
SecondarySafety of mEPICUp to 3 weeks (assessed during the hospitalization following the participant's surgery).Evaluate the safety of the mEPIC protocol by monitoring adverse events arising during the protocol.
SecondarySatisfaction of care team2 days (assessed during mEPIC protocol)
Assess satisfaction of care team including surgery and nursing teams regarding the implementation process of the mEPIC protocol. It is evaluated using a questionnaire form collecting comments from the care team about logistical barriers encountered during mEPIC protocol.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers15

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
1831736BACKGROUNDPubMed
2118420BACKGROUNDPubMed
2688796BACKGROUNDPubMed
8980409BACKGROUNDPubMed
9440757BACKGROUNDPubMed
9499187BACKGROUNDPubMed
9807659BACKGROUNDPubMed
11320672BACKGROUNDPubMed
16047145BACKGROUNDPubMed
22778722BACKGROUNDPubMed

1 to 10 of 15

See all 15 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05913674

GET https://conductscience.org/api/trials/v1/NCT05913674/registered